A 28-year-old woman from Delhi presents with a 10-day history of high-grade fever (39.5°C), headache, and abdominal pain. She reports constipation initially, followed by loose stools for the past 2 days. On examination, she has hepatosplenomegaly and a faint maculopapular rash on the trunk. Blood culture is pending. A peripheral smear shows no parasites. Widal test shows O antigen titre of 1:320 and H antigen titre of 1:160. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis and Management Rationale ### Diagnosis Confirmation **Key Point:** The clinical presentation (prolonged fever, headache, rose spots, hepatosplenomegaly, constipation followed by diarrhoea) combined with Widal serology (O and H antigen positivity) is diagnostic of enteric fever (typhoid fever). **High-Yield:** Widal test interpretation: - O antigen titre ≥1:320 = current/recent infection - H antigen titre ≥1:160 = current/recent infection - Both positive in this case = highly suggestive of acute typhoid ### Antibiotic Selection in Current Era | Feature | Chloramphenicol | Fluoroquinolones | Cephalosporins (3rd Gen) | |---------|-----------------|------------------|------------------------| | **Resistance Pattern** | High (>50% in India) | High (QRST strains) | Low (<5%) | | **Current DOC Status** | Obsolete | Conditional (resistance emerging) | **First-line** | | **CNS Penetration** | Excellent | Good | Good | | **Adverse Effects** | Aplastic anaemia (rare but serious) | GI upset, tendinitis | Generally safe | | **Efficacy in India** | Poor due to resistance | Declining efficacy | Excellent | **Clinical Pearl:** In India, resistance patterns have shifted dramatically. Chloramphenicol is no longer recommended due to widespread resistance and risk of aplastic anaemia. Fluoroquinolones, once first-line, now show 30–40% resistance (quinolone-resistant Salmonella typhi — QRST strains). ### Why Ceftriaxone? **Key Point:** Third-generation cephalosporins (ceftriaxone 2 g IV 12-hourly or cefixime 200–400 mg BD orally) are now the **gold standard** for enteric fever in India [cite:Park 26e Ch 5]. 1. **Low resistance rates** (<5% in most Indian centres) 2. **Excellent tissue penetration**, including CNS (important if complications develop) 3. **Rapid defervescence** (fever typically resolves in 3–5 days) 4. **Safe in pregnancy** (if applicable) 5. **Blood culture should be obtained first** — this is standard practice, but antibiotics should NOT be delayed awaiting results if clinical suspicion is high **Mnemonic for Enteric Fever Antibiotic Ladder (Modern India):** **CFQ** = Cephalosporin (first-line) → Fluoroquinolone (if resistance/allergy) → Quinolone alternatives. ### Timing of Antibiotic Initiation **Warning:** Do NOT delay antibiotics awaiting culture results if clinical diagnosis is highly probable. Blood culture positivity is only 40–50% even in untreated cases, and delay increases morbidity and mortality. **High-Yield:** Start antibiotics immediately after blood culture is drawn (not after results return). This patient has: - Classic clinical presentation - Positive Widal serology - High pre-test probability ## Duration and Follow-up - **Duration:** 7–10 days IV ceftriaxone (or 14 days if complications like encephalitis) - **Defervescence:** Expected in 3–5 days - **Repeat blood culture:** If fever persists >5 days on appropriate therapy (suggests complicated typhoid or alternative diagnosis) - **Relapse monitoring:** 1–5% relapse rate; educate patient on warning signs ## Chronic Carrier State **Clinical Pearl:** 1–5% of patients become chronic carriers (>1 year shedding in stool). Counsel on hygiene and consider ciprofloxacin 500 mg BD × 28 days if carrier state develops.